Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FEJBE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,992
Award facts
- Contract value 100% obligated
- $36,992.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,992.04 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This firm fixed-price, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of October 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
Benlysta (belimumab) is a monoclonal antibody therapeutic used primarily in the treatment of systemic lupus erythematosus and other autoimmune conditions. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages its extensive supply chain capabilities to provide brand-name and generic medications, vaccines, and specialized medical supplies to military and veteran healthcare systems. The award demonstrates the company's ability to meet competitive federal procurement requirements and support the Defense Health Agency and other government healthcare systems through its flexible IDC vehicle, which encompasses multiple therapeutic domains and serves as a critical global pharmaceutical supply source for military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FEJBE?
SPE2DB25FEJBE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FEJBE worth?
The government has obligated $36,992 on SPE2DB25FEJBE.
Is contract SPE2DB25FEJBE an order under another contract?
Yes. SPE2DB25FEJBE is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEJBE competed?
The extent of competition for SPE2DB25FEJBE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award